QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 244 filers reported holding QIAGEN NV in Q3 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2023 | $1,147 | -7.9% | 25 | 0.0% | 0.00% | – |
| Q4 2022 | $1,246 | – | 25 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 25 | -83.3% | 0.00% | – |
| Q2 2022 | $6,000 | 0.0% | 150 | +18.1% | 0.00% | – |
| Q1 2022 | $6,000 | -14.3% | 127 | +8.5% | 0.00% | – |
| Q4 2021 | $7,000 | +16.7% | 117 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | – | 117 | +963.6% | 0.00% | – |
| Q1 2021 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 11 | -81.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 58 | +427.3% | 0.00% | – |
| Q3 2019 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 11 | +37.5% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 8 | -97.8% | 0.00% | -100.0% |
| Q1 2017 | $10,000 | – | 360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
| Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
| Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
| Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
| RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
| SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
| FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
| Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
| Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |